Trevi Therapeutics

1 follower

‌

Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.

Industries

Biotechnology, Education

Headquarters

New Haven, United States

Employees

11-50

Links

Org chart

Jennifer Good

Co-Founder, President & CEO

Jennifer Good

Collapse

Thomas Sciascia

Co-Founder, Chief Science Officer

Lisa Delfini

CFO

David Clark

Chief Medical Officer

Farrell Simon

Chief Commercial Officer

Katherine Takaki

VP, Global Regulatory Affairs

Katie McManus

Senior Manager, Marketing & Communications

Paula Buckley

VP, Clinical Operations

Pam Nieves

Associate Director, Quality Assurance & Compliance

Teams

Regulatory and Compliance

5 members

Leadership Team

3 members

Medical Affairs and Commercial Strategy

4 members

Clinical Operations

3 members

Finance and Accounting

3 members

Similar companies

Vaxcyte

2 followers

FieldGuide

2 followers

89bio

2 followers

Apogee Therapeutics

1 follower

PrognomiQ

1 follower

Alveo Technologies

1 follower

Twist Bioscience

12 followers

Ginkgo Bioworks

14 followers

QbDVision

1 follower

Thermo Fisher Scientific

165 followers

Pearson

59 followers

Explore companies